Peer Review History
| Original SubmissionMay 26, 2023 |
|---|
|
PONE-D-23-14072The sequence of oblique lumbar interbody fusion: reduction first or cage first?PLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== General: The title of the manuscript is not representing the core principle of the methodology (spinal navigation) and findings of the manuscript Lines 28-30 & 61-63: Oblique lumbar interbody fusion (OLIF) procedures are divided into anterior insertion of interbody cage first in lateral position and insertion of pedicle screw and rod system in a prone position (OLIF-con). " I absolutely disagree with the authors. OLIF is an anterior interbody fusion performed through lateral approach involves an oblique channel between the prevertebral venous structures and the psoas muscle. Transpedicular fixation is not a part of OLIF technique. It is a supplementary ‘complementary” fixation that adds to the stability of the construct. This point is very important, makes the manuscript confusing at several sentences and should be corrected. Introduction . Lines 59-60: “For these purposes, an interbody cage is usually inserted into the anterior one-third of the disc space in OLIF [5]”. The same meaning was repeated again in lines 63-64: “The location of the cage is crucial for restoring lumbar lordosis and providing indirect decompression” This repetition should be omitted. . Lines 70-72: “Consequently, the surgeon can switch the sequences of posterior and anterior surgical procedures in one position by moving the front and back of the patient” This sentence is unclear and confusing. I think it should be corrected to: “The surgeon can move to anterior or posterior aspect of the patient because both approaches could be used at the same time.” . Line 76: I think the term “inserted” should be better used instead of “located” Methods . Lines 88-91: “All patients with spondylolisthesis greater than 3mm were included without any exclusion criteria, as the purpose of the study was to compare immediate postoperative radiologic and clinical outcomes” What is the relation between inclusion of all patients with spondylolisthesis greater than 3 mm and the purpose to study immediate post-operative radiologic and clinical outcomes? . Lines 140-141: “Then, the surgeon moved to the back of the patient, and used the same specialized reducing device as in OLIF-con, with an undersized trial cage, to reduce the spondylolisthesis.” This sentence is confusing. The surgeons have already inserted the trial cage through the lateral position then moved to the back of the patient to do reduction utilizing the reduction system. So, I think the words “with an undersized trial cage” should be deleted. . Lines 142- 143: “After the reduction of spondylolisthesis, the set screws were inserted but not broken off to allow for sliding of the vertebra along the rod during the insertion of the interbody cage.” This sentence is confusing and unclear. . Results . Lines 190-192: “Surgical time was not significantly different between OLIF-con (268 ± 82.5 minutes) and OLIF-one (215 ± 42.8 minutes) (p = .10).” Better to be changed to “Surgical time was shorter in OLIF-one (215 ± 42.8 minutes) than in OLIF-con (268 ± 82.5 minutes), however the difference did not reach statistical significance (p = .10).” . Table 1: The statistical difference between the 2 groups as regards male/female ratio should be reported. I think this can be examined by 2x2 contiguency table. The same as regards the difference between the number of levels in the 2 groups utilizing MxN contiguncy tables. . Conclusion . Lines 300-302: “This is the first study to demonstrate the outcome of switching the procedures during OLIF using surgical navigation. OLIF-one facilitated the reduction of spondylolisthesis and precise cage placement at the optimal position. ” This sentence should be corrected to: “This is the first study to show superior results of performing OLIF with supplementary transpedicular fixation of spondylolisthesis in one lateral position utilizing spinal navigation system. Even more, this technique facilitated the reduction of spondylolisthesis and precise cage placement at the optimal position” ============================== Please submit your revised manuscript by Jul 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed El-Sayed Abdel-Wanis, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "This study was supported by Seoul National University Hospital research fund (grant no. 04-2021-0540, CHK); and by the Doosan Yonkang Foundation (800-20210527, CHK)." Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1.Spondylolisthesis are heterogenous group based on etiology, disc height and degree of severity, please include those information as well 2.Please give information about detailed information about the temporary sensory and motor deficit Reviewer #2: • Line 78: Term OLIF con used. This terminology probably explained in line 73. Kindly do it clearly. Similarly, it is confusing sequence at line 118. • OLIF con is open procedure with front back sequence and OLIF one is MIS navigation procedure with back, front back sequence? • Industry name mentioned on line 113. (CD Horizon® Longitude® II fixation system, Medtronic Sofamor Danek USA Inc., Memphis, TN, USA) • On page 122 again industry name spinal navigation guidance (O-arm™ Surgical Imaging Systems, • 123 Medtronic Sofamor Danek USA Inc., Memphis, TN, USA). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-14072R1Efficacy of navigation-guided pedicle screw fixation followed by oblique lumbar interbody fusion for the reduction of spondylolisthesisPLOS ONE Dear Dr. Chi Heon Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Thank you for addressing the reviewer and editorial comments. However, in my opinion, there is still improvement potentials. ============================== Please submit your revised manuscript by Sep 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed El-Sayed Abdel-Wanis, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The authors addressed almost all the reviewers and editorial comments. However, as regards the title, I think still the title is not representing the core importance of the study. I would suggest the following title: SURGICAL TREATMENT OF SPONDYLOLITHESIS BY OLIF AND TRANSPEDICULAR SCREW FIXATION: COMPARISNON BETWEEN CONVENTIONAL DOUBLE POSITION VERSUS NAVIGATION- ASSISTED SINGLE LATERAL POSITION. Consequently, the short title should be also changed. I would suggest: single versus double position OLIF and transpedicular screw fixation [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Surgical treatment of spondylolisthesis by oblique lumbar interbody fusion and transpedicular screw fixation: comparison between conventional double position versus navigation-assisted single lateral position PONE-D-23-14072R2 Dear Dr. Chi Heon Kim We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohamed El-Sayed Abdel-Wanis, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-14072R2 Surgical treatment of spondylolisthesis by oblique lumbar interbody fusion and transpedicular screw fixation: comparison between conventional double position versus navigation-assisted single lateral position Dear Dr. Kim: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr Mohamed El-Sayed Abdel-Wanis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .